Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT00194467
Eligibility Criteria:
Inclusion Criteria:
* 18 years or older
* HHV-8 seropositive or previous evidence of HHV-8 shedding
* a frequent shedder of HHV-8
* not receiving any drugs with known anti-HHV-8 activity for study duration
* able to comply with the study protocol
* agree to HIV testing
Exclusion Criteria:
* history of evidence of CMV disease
* hypersensitivity to ganciclovir or valganciclovir
* use of high-dose acyclovir, valacyclovir, famciclovir, ganciclovir, foscarnet, or cidofovir
* neutropenia
* renal insufficiency with serum creatinine greater than 1.5mg.ml or CrCl less than 60
* AST or ALT greater than 5 times upper limit of normal
* concurrent administration of medications which are often associated with severe neutropenia or thrombocytopenia
* concurrent administration of probenecid or didanosine
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00194467
Study Brief:
Protocol Section:
NCT00194467